Search results for "DEGENERATION"

showing 10 items of 601 documents

Effet neuroprotecteur de l’accident ischémique transitoire

2011

Transient ischemic attack (TIA) is a well-recognized risk factor of ischemic stroke. Hence, 7 to 25% of ischemic stroke patients have a history of TIA, and the risk of ischemic stroke after TIA is about 15% at 3 months. However, epidemiological studies have demonstrated that among patients with ischemic stroke, those with a history of TIA have better functional and vital prognoses. This protective effect is particularly found in case of recent and short TIA, and in case of non-lacunar ischemic stroke. Hence, TIA can induce endogenous neuroprotection by the ischemic tolerance phenomenon that decreases the neurodegeneration usually caused by a severe cerebral ischemia in a non-preconditioned …

medicine.medical_specialtybusiness.industryNeurodegenerationIschemiaGeneral Medicine030204 cardiovascular system & hematologymedicine.diseaseNeuroprotectionnervous system diseases3. Good healthSurgery03 medical and health sciences0302 clinical medicineInternal medicineparasitic diseasesIschemic strokeCardiologyMedicinecardiovascular diseasesRisk factorbusiness030217 neurology & neurosurgeryLa Presse Médicale
researchProduct

Potential Involvement of Impaired Venous Outflow from the Brain in Neurodegeneration: Lessons Learned from the Research on Chronic Cerebrospinal Veno…

2019

About 10 years ago, the so-called chronic cerebrospinal venous insufficiency syndrome was discovered. This clinical entity, which is associated with extracranial venous abnormalities that impair venous outflow from the brain, was initially found exclusively in multiple sclerosis patients. Currently, we know that such venous lesions can also be revealed in other neurological pathologies, including Alzheimer’s and Parkinson’s diseases. Although direct causative role of chronic cerebrospinal venous insufficiency in these neurological diseases still remains elusive, in this paper, we suggest that perhaps an abnormal venous drainage of the brain affects functioning of the glymphatic system, whi…

medicine.medical_specialtychronic cerebrospinal venous insufficiencyDisease030204 cardiovascular system & hematologymultiple sclerosisjugular vein03 medical and health sciences0302 clinical medicineCerebrospinal fluidInternal medicineCranial cavitymedicineballoon angioplastyHumansPharmacologybusiness.industryMultiple sclerosisNeurodegenerationneurodegenerationBrainNeurodegenerative DiseasesGeneral Medicinemedicine.diseaseParkinson diseaseChronic cerebrospinal venous insufficiencymedicine.anatomical_structureVenous InsufficiencyRegional Blood FlowCerebrovascular CirculationChronic DiseaseCardiologyGlymphatic systemAlzheimer's diseaseAlzheimer diseaseJugular Veinsbusiness030217 neurology & neurosurgeryReviews on recent clinical trials
researchProduct

The LDL receptor in the retina: the missing link in aging, the new target in dietary prevention

2012

National audience; Purpose: The discovery of the LDL receptor (LDLR) in 1985 by Brown and Goldstein was awarded by a Nobel Prize. The LDLR has initially been identified for its role in mediating the endocytosis of LDL particles in the vascular endothelium. The deposition of lipids, including cholesterol and cholesteryl esters in Bruch’s Membrane in the one hand, and in the vessel intima in the other hand, is one of the common features of age related macular degeneration (AMD) and cardiovascular disease (CVD). Dietary habits with high intakes of omega 3 long chain fatty acids (LCFA) have been associated with AMD prevention. Similar effects have been demonstrated in CVD prevention. The mechan…

medicine.medical_specialtygenetic structures030309 nutrition & dieteticsLinoleic acidEndocytosis03 medical and health scienceschemistry.chemical_compound0404 agricultural biotechnologyInternal medicineGene expressionmedicinecardiovascular diseases[SDV.MHEP.OS]Life Sciences [q-bio]/Human health and pathology/Sensory Organs0303 health sciencesRetinaCholesterolbusiness.industry04 agricultural and veterinary sciencesGeneral MedicineMacular degenerationmedicine.disease040401 food scienceeye diseases3. Good healthOphthalmologyEndocrinologymedicine.anatomical_structurechemistryHumanized mouseLDL receptorlipids (amino acids peptides and proteins)sense organsbusiness[SDV.AEN]Life Sciences [q-bio]/Food and Nutrition[SDV.MHEP]Life Sciences [q-bio]/Human health and pathology
researchProduct

Evolving European guidance on the medical management of neovascular age related macular degeneration

2006

BACKGROUND: Until recently, only two options were available for the treatment of choroidal neovascularisation (CNV) associated with age related macular degeneration (AMD)-thermal laser photocoagulation and photodynamic therapy with verteporfin (PDT-V). However, new treatments for CNV are in development, and data from phase III clinical trials of some of these pharmacological interventions are now available. In light of these new data, expert guidance is required to enable retina specialists with expertise in the management of AMD to select and use the most appropriate therapies for the treatment of neovascular AMD. METHODS: Consensus from a round table of European retina specialists was obt…

medicine.medical_specialtygenetic structuresBevacizumabAntibodies Monoclonal HumanizedTriamcinolone AcetonideMacular DegenerationCellular and Molecular NeuroscienceRanibizumabOphthalmologymedicineHumansPregnadienediolsEvidence-Based Medicinemedicine.diagnostic_testbusiness.industryAntibodies MonoclonalAptamers NucleotideMacular degenerationFluorescein angiographymedicine.diseaseVerteporfinChoroidal Neovascularizationeye diseasesSensory SystemsOphthalmologyTreatment Outcomemedicine.anatomical_structureChoroidal neovascularizationPhotochemotherapyPerspectivesense organsAnecortave acetateChoroidRanibizumabmedicine.symptombusinessmedicine.drugBritish Journal of Ophthalmology
researchProduct

Eye disease and mortality, cognition, disease, and modifiable risk factors: an umbrella review of meta-analyses of observational studies

2022

Globally, 2.2 billion people live with some form of vision impairment and/or eye disease. To date, most systematic reviews examining associations have focused on a single eye disease and there is no systematic evaluation of the relationships between eye diseases and diverse physical and mental health outcomes. Moreover, the strength and reliability of the literature is unclear. We performed an umbrella review of observational studies with meta analyses for any physical and/or mental comorbidities associated with eye disease. For each association, random-effects summary effect size, heterogeneity, small-study effect, excess significance bias and 95% prediction intervals were calculated, and …

medicine.medical_specialtygenetic structuresEye diseaseDiseaseType 2 diabetesReview ArticleCataractCognitionEye diseasePregnancyRisk FactorsDiabetes mellitusInternal medicinemedicineHumansDepression (differential diagnoses)Diabetic Retinopathybusiness.industryInfant NewbornReproducibility of ResultsRetinopathy of prematurityGlaucomaDiabetic retinopathyMacular degenerationmedicine.diseaseeye diseasesOphthalmologyObservational Studies as TopicDiabetes Mellitus Type 2Femalebusiness
researchProduct

Current Clinical Application of Microperimetry: A Review.

2018

Microperimetry (MP) is a technology that allows the study of retinal sensitivity at different foveal and parafoveal areas as well as eye fixation. It is a technique of functional evaluation, providing a direct correlation between anatomical and functional outcomes. There are a great variety of studies which evaluate the repeatability or reliability of measurements obtained with this technology and also describe and explore different clinical applications. MP has been shown to be useful in the characterization of sensory and motor conditions, such as amblyopia or nystagmus. Concerning ocular pathology, several studies have confirmed the usefulness of MP for evaluating and analyzing different…

medicine.medical_specialtygenetic structuresOcular PathologyGlaucomaNystagmusFixation OcularAmblyopiaMicroperimetryOcular Motility Disorders03 medical and health scienceschemistry.chemical_compoundNystagmus0302 clinical medicineOcular Motility DisordersRetinal DiseasesFovealOphthalmologymedicineHumansRetinal sensitivityVisual rehabilitationÓpticabusiness.industryReproducibility of ResultsRetinalGeneral MedicineMacular degenerationmedicine.diseaseeye diseasesOphthalmologychemistryEye fixation030221 ophthalmology & optometryVisual Field Testsmedicine.symptomVisual FieldsbusinessMicroperimetry030217 neurology & neurosurgerySeminars in ophthalmology
researchProduct

Spotlight on fundus autofluorescence.

2018

Fundus autofluorescence (FAF) imaging is based on the fluorescence from ocular endogenous fluorophores located in the retinal pigment epithelium and choroid, mainly lipofuscin and melanin. It is a noninvasive technique that provides information about the spatial distribution of lipofuscin/melanin and retinal pigment epithelium health status. An overview about the fluorophores responsible for FAF imaging and the usefulness of FAF imaging in the noninvasive assessment and monitoring of retinal diseases, such as age-related macular degeneration, diabetic retinopathy, diabetic macular edema, central serous chorioretinopthy, retinitis pigmentosa and retinal dystrophies, are discussed in this rev…

medicine.medical_specialtygenetic structuresReviewLipofuscinchemistry.chemical_compoundOphthalmologyRetinitis pigmentosamedicinelipofuscinRetinal pigment epitheliumfundus autofluorescencebusiness.industrynear-infrared fundus autofluorescenceshort-wavelength fundus autofluorescenceRetinalDiabetic retinopathyMacular degenerationmedicine.diseaseSensory Systemseye diseasesmelaninOphthalmologymedicine.anatomical_structurechemistryChoroidsense organsbusinessRetinal DystrophiesClinical optometry
researchProduct

Eclectic Ocular Comorbidities and Systemic Diseases with Eye Involvement: A Review.

2016

Coexistence of several ocular diseases is more frequent than suspected. In spite of the refractive errors, one or more of the following can be detected simultaneously: glaucoma, cataracts, uveitis, age-related macular degeneration, and dry eyes. In addition, as people age, ocular comorbidities are much more usually seen. Specific diseases are openly acknowledged to affect the eyes and vision, such as diabetes mellitus, hypertension blood pressure, arthritis, hyperthyroidism, neurodegenerative disorders, hematologic malignancies, and/or systemic infections. Recent advances in early diagnosis and therapy of the ophthalmic pathologies have reinforced patient options to prevent visual impairmen…

medicine.medical_specialtygenetic structuresVisual impairmentGlaucomalcsh:MedicineContext (language use)Review ArticleGeneral Biochemistry Genetics and Molecular Biologycomorbidity; humans; eye diseases03 medical and health sciences0302 clinical medicineCataractsDiabetes mellitusmedicineIntensive care medicinehumansGeneral Immunology and Microbiologybusiness.industrySettore MED/30 - Malattie Apparato Visivolcsh:Reye diseasesGeneral MedicineMacular degenerationmedicine.diseaseComorbidityeye diseasescomorbidity030221 ophthalmology & optometryPhysical therapysense organsmedicine.symptombusiness030217 neurology & neurosurgeryUveitis
researchProduct

Proteomics in ocular fluids

2007

The focus of this article is to review recent techniques in proteomic analysis of ocular fluids. These fluids include tears, aqueous humor, and vitreous, they will also be compared to serum analysis. Furthermore, we attempt to summarize some disease correlated biomarkers in ocular fluids that were discovered through different proteomic techniques in eye diseases like dry eye, glaucoma, age-related macular degeneration, uveitis, or diabetic retinopathy. This review is trying to point out the importance of these biomarkers for clinical applications.

medicine.medical_specialtygenetic structuresbusiness.industryClinical BiochemistryGlaucomaAqueous humorDiabetic retinopathyMacular degenerationmedicine.diseaseProteomicseye diseasesOphthalmologymedicineTearssense organsbusinessUveitisPROTEOMICS – CLINICAL APPLICATIONS
researchProduct

Transpupillary thermotherapy (TTT) for age-related macular degeneration (AMD) – Is it time to say good-bye?

2010

Abstract Purpose To evaluate the effectiveness of transpupillary thermotherapy (TTT) for the closure of classic and occult subfoveal choroidal neovascularization (CNV) and to discuss whether TTT is a useful treatment modality for age-related macular degeneration (AMD). Materials and methods The present paper is a retrospective review of the clinical results from a patient group which was treated with TTT in the University Eye Clinic in Mainz. From January 2000 to December 2002, a total of 20 eyes of 20 patients with subfoveal CNV (due to AMD in 16 eyes, due to pathologic myopia in 4 eyes) received TTT. The procedure was delivered using an infrared diode laser at 810 nm, equipped with a modi…

medicine.medical_specialtygenetic structuresbusiness.industryDermatologyMacular degenerationmedicine.diseaseOcculteye diseasesLesionContact lensChoroidal neovascularizationAtrophyOphthalmologyOcclusionmedicineSurgeryMetamorphopsiasense organsmedicine.symptombusinessMedical Laser Application
researchProduct